Treatment of breast cancer (BC) has recently progressed via combinations of standard approaches, including surgery, chemotherapy, radiotherapy, hormonal therapy (for hormone receptor positive types of BC), targeted therapy [1], and/or therapy using immune checkpoint inhibitors such as Pembrolizumab [2]. Here, NR4A1 is linked to breast cancer.